The eFlow®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the lower airways. It stands for efficient, safe and fast inhalation treatment, combined with even more advantages:
1 Naehrig S et al. Eur J Med Res 2011; 16(2): 63-6
Aerosol characteristics of the eFlow®rapid nebuliser system
MMADa): 4,6 µm
Respirable Fractiona) < 5 µm: 55 %
Aerosol Output Rateb): 0,5 g/min
Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.
a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min
b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).
For more technical information please see the Instructions for use.
Click on the video links below to find out more about the topics listed. Please always follow the respective instructions for use.
Service is essential to keep medical equipment operational and safe. Our Nordic service team consists of experienced service technicians stationed across the Nordic countries. Our service technicians are ready to take on your every service need.”

Nasal PAP ventilation system
The SuperNO2VA nasal PAP ventilation system uses the flow from any oxygen source. Delivers positive airway pressure to stent open the upper airway, allowing for the preoperative delivery of positive pressure ventilation and oxygen for patients with a decreased level of consciousness. The SuperNO2VA™ nasal PAP ventilation device is available in medium and large sizes and is offered as a standalone mask with a head strap and as a system, kitted with a hyperinflation bag. These configurations offer flexibility as it allows the SuperNO2VA™ nasal PAP ventilation device to be used with either an anesthesia machine or with only an oxygen flow meter.

Meeting the needs of medical staff and patients
The Vivo 55 is an advanced homecare ventilator designed to deliver secure and comfortable treatment to patients from 10 kg. The Vivo 55 can be used for a wide variety of patients, both life-support and non life-support, thanks to a comprehensive set of modes, circuits and accessories.
The Vivo 55 is designed to meet the needs both of medical staff and a wide range of patients. It combines comfortable and controllable ventilation with excellent monitoring capabilities to potentially reduce readmissions to acute care facilities. The extensive monitoring capabilities help obtain a better insight into the quality of ventilation. The Vivo 55 is an excellent choice for mechanical ventilation at home, in the hospital and in long-term care facilities. The Vivo 55 is prepared for connection to Breas cloud solutions.

For accurate and safe bronchial challenge testing
Vyntus APS is an Aerosol Provocation System. Up-to-date and sophisticated electronics and mechanics allow for optimal use of its nebulization technology with precise dosing. For the observation measurements Vyntus APS combines with the Vyntus PNEUMO and/ or the Vyntus IOS in one system.
APS nebulizer system integrates into Vyaire MasterScreen™ and Vyntus™ instruments – Spirometry, IOS Impulse Oscillometry, Rocc and BODY Plethysmography. The nebulizer system is powered by SentrySuite™ software and is able to test a broad age range: from 4 years to adult. Choose between single and multiple concentration testing.

The dual-valved LiteAire MDI holding chamber: Collapsible, disposable paperboard design.
The LiteAire® collapsible MDI holding chamber is a unique MDI holding chamber and an innovative alternative. LiteAire’s unique dual-valved MDI holding chamber design delivers pop-up convenience and effective drug output at a fraction of the cost of most plastic holding chambers. In many clinical settings, the LiteAire can reduce costs by replacing existing rigid plastic holding chambers or inefficient spacers with a paperboard alternative. The unique design allows the LiteAire to be reused by a patient over multiple doses and meets and often exceeds the performance of plastic holding chambers.